Johnson & Johnson Stock Update: Mixed Signals, Analysts Bullish, Defensive Appeal in Volatile Market

# Johnson & Johnson (JNJ) Stock Analysis: Growth Catalysts, Analyst Upgrades & Tariff Deal Dive into our comprehensive analysis of Johnson & Johnson's current market position, trading at $204.41. Discover how JNJ's Trump administration deal for tariff exemptions and $55B manufacturing expansion could impact investors, alongside promising clinical developments for nipocalimab and the Ottava surgical robot. We break down recent analyst upgrades from Citigroup, Bank of America, and others, explaining why JNJ maintains a "Moderate Buy" consensus with a $213.33 price target. Learn why this healthcare giant's 2.51% dividend yield and defensive profile might make it an attractive option during market volatility. Subscribe for more expert financial insights from Quiet Please. For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.